Lemtrada

Autoimmune Hepatitis, Haemophagocytic Lymphohistiocytosis, and Cardiovascular Complications all Associated with Multiple Sclerosis Drug LEMTRADA USA- Healthycanadians.gc.ca reports that LEMTRADA, a form of treatment for multiple sclerosis (MS), has been linked to [...]

CANADA- Healthycanadians.gc.ca writes that LEMTRADA presents certain serious health risks for patients who undergo treatment with the prescription drug. LEMTRADA is prescribed to patients with relapsing-remitting multiple sclerosis. Typically, this medication [...]

Lemtrada is a medication used in certain patients who are being treated for multiple sclerosis. After this drug went onto the market, severe and sometimes life-threatening complications started to be [...]

CANADA- Healthycanadians.gc.ca reports that Lemtrada, or alemtuzumab, presents risks to patients beyond the previously known side-effects. The government issued a warning targeted at health care providers and alerting them of the [...]

Parker Waichman LLP Announces Investigation into Multiple Sclerosis Drug That Can Cause Stroke or Death Nationally renowned drug-defect attorneys Parker Waichman LLP announce that their firm has opened an investigation [...]

The U.S. Food and Drug Administration (FDA) announced that the drug Lemtrada, also known as Campath (alemtuzumab), carries with it the chance that a patient suffering from relapsing multiple sclerosis [...]

Multiple sclerosis (MS) is a varied, debilitating condition, with differing symptoms and pathology. On Nov. 29th, the Food and Drug Administration (FDA) released a safety announcement warning that warned that [...]